Protein transduction: unrestricted delivery into all cells?

Green, 1988, Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein, Cell, 55, 1179, 10.1016/0092-8674(88)90262-0 Frankel, 1988, Cellular uptake of the Tat protein from human immunodeficiency virus, Cell, 55, 1189, 10.1016/0092-8674(88)90263-2 Joliot, 1991, Antennapedia homeobox peptide regulates neural morphogenesis, Proc. Natl. Acad. Sci. U. S. A., 88, 1864, 10.1073/pnas.88.5.1864 Elliott, 1997, Intercellular trafficking and protein delivery by a herpesvirus structural protein, Cell, 88, 223, 10.1016/S0092-8674(00)81843-7 Hawiger, 1999, Noninvasive intracellular delivery of functional peptides and proteins, Curr. Opin. Chem. Biol., 3, 89, 10.1016/S1367-5931(99)80016-7 Mann, 1991, Endocytosis and targeting of exogenous HIV-1 Tat protein, EMBO. J., 10, 1733, 10.1002/j.1460-2075.1991.tb07697.x Derossi, 1994, The third helix of the Antennapedia homeodomain translocates through biological membranes, J. Biol. Chem., 269, 10444, 10.1016/S0021-9258(17)34080-2 Derossi, 1996, Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent, J. Biol. Chem., 271, 18188, 10.1074/jbc.271.30.18188 Vives, 1997, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem., 272, 16010, 10.1074/jbc.272.25.16010 Bonifaci, 1995, Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding, AIDS, 9, 995, 10.1097/00002030-199509000-00003 Calnan, 1991, Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA–protein recognition, Genes Dev., 5, 201, 10.1101/gad.5.2.201 Loret, 1991, Activating region of HIV-1 Tat protein, Biochemistry, 30, 6013, 10.1021/bi00238a027 Mabrouk, 1991, Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins, FEBS Lett., 289, 13, 10.1016/0014-5793(91)80898-D Derossi, 1998, Trojan peptides, Trends Cell Biol., 8, 84, 10.1016/S0962-8924(97)01214-2 Fawell, 1994, Tat-mediated delivery of heterologous proteins into cells, Proc. Natl. Acad. Sci. U. S. A., 91, 664, 10.1073/pnas.91.2.664 Schwarze, 1999, In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, 285, 1569, 10.1126/science.285.5433.1569 Lewin, 2000, Tat peptide derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat. Biotechnol., 18, 410, 10.1038/74464 Allinquant, 1995, Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro, J. Cell Biol., 128, 919, 10.1083/jcb.128.5.919 Anderson, 1993, Tumour cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide, Biochem. Biophys. Res. Commun., 194, 876, 10.1006/bbrc.1993.1903 Pooga, 1998, Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo, Nat. Biotechnol., 16, 857, 10.1038/nbt0998-857 Ezhevsky, 1997, Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb, Proc. Natl. Acad. Sci. U. S. A., 94, 10699, 10.1073/pnas.94.20.10699 Nagahara, 1998, Transduction of full-length TAT fusion proteins into mammalian cells, Nat. Med., 4, 1449, 10.1038/4042 Prochiantz, 1996, Getting hydrophilic compounds into cells, Curr. Opin. Neurobiol., 6, 629, 10.1016/S0959-4388(96)80095-X Chen, 1999, Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists, Proc. Natl. Acad. Sci. U. S. A., 96, 4325, 10.1073/pnas.96.8.4325 Gius, 1999, Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1, Cancer Res., 59, 2577 Elliott, 1999, Intercellular trafficking of VP22–GFP fusion proteins, Gene Ther., 6, 149, 10.1038/sj.gt.3300850 Lissy, 1998, TCR–antigen induced cell death (AID) occurs from a late G1 phase cell cycle check point, Immunity, 8, 57, 10.1016/S1074-7613(00)80458-6 Vocero-Akbani, 1999, Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein, Nat. Med., 5, 29, 10.1038/4710 Chellaiah, 2000, Rho-A is critical for osteoclast podosome organization, motility and bone resorption, J. Biol. Chem., 275, 11993, 10.1074/jbc.275.16.11993 Algeciras-Schimnich, 1999, Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis, J. Immunol., 162, 5205, 10.4049/jimmunol.162.9.5205 Schutze-Redelmeier, 1996, Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila Antennapedia homeodomain primes cytotoxic T cells in vivo, J. Immunol., 157, 650, 10.4049/jimmunol.157.2.650 Fenton, 1998, The efficient and rapid import of a peptide into primary B and T lymphocytes and a lymphoblastoid cell line, J. Immunol. Methods, 212, 41, 10.1016/S0022-1759(97)00208-1 Barry, 1997, Requirement for Rho in integrin signalling, Cell Adhes. Commun., 4, 387, 10.3109/15419069709004456 Zhong, 1997, Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells, Mol. Biol. Cell, 8, 2329, 10.1091/mbc.8.11.2329 Ridley, 1992, The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibres in response to growth factors, Cell, 70, 389, 10.1016/0092-8674(92)90163-7 Lakkakorpi, 1996, Cytoskeletal changes in osteoclasts during the resorption cycle, Microsc. Res. Tech., 33, 171, 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W Kanehisa, 1988, Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts, Bone, 9, 73, 10.1016/8756-3282(88)90106-8 Chellaiah, 1998, c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase, J. Biol. Chem., 273, 11908, 10.1074/jbc.273.19.11908 Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 Phelan, 1998, Intercellular delivery of functional p53 by the herpesvirus protein VP22, Nat. Biotechnol., 16, 440, 10.1038/nbt0598-440